ClinicalTrials.gov
public full text
Public Domain
Resveratrol in Treating Patients With Colorectal Cancer That Can Be Removed By Surgery
This phase I trial is studying the side effects and best dose of resveratrol in treating patients with colorectal cancer that can be removed by surgery. Resveratrol may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Effect of Resveratrol on Serum IGF2 Among African American Women#848679
- Regulation of Intestinal and Hepatic Lipoprotein Secretion by Resveratrol#1046080
- Dasatinib in Treating Patients With Previously Treated Metastatic Colorectal Cancer#1173382
- Determining the Ability of Resveratrol to Inhibit HCBR Activity#493125
- Fluorouracil and Irinotecan With or Without Leucovorin Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer#1126903
Record · ID 831572
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive